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Abstract
Although over 50 genes are known to cause renal malformation if mutated, the underlying genetic basis, most easily
identified in syndromic cases, remains unsolved in most patients. In search of novel causative genes, whole-exome
sequencing in a patient with renal, i.e., crossed fused renal ectopia, and extrarenal, i.e., skeletal, eye, and ear, malformations
yielded a rare heterozygous variant in the GDF6 gene encoding growth differentiation factor 6, a member of the BMP family
of ligands. Previously, GDF6 variants were reported to cause pleiotropic defects including skeletal, e.g., vertebral, carpal,
tarsal fusions, and ocular, e.g., microphthalmia and coloboma, phenotypes. To assess the role of GDF6 in the pathogenesis
of renal malformation, we performed targeted sequencing in 193 further patients identifying rare GDF6 variants in two cases
with kidney hypodysplasia and extrarenal manifestations. During development, gdf6 was expressed in the pronephric tubule
of Xenopus laevis, and Gdf6 expression was observed in the ureteric tree of the murine kidney by RNA in situ hybridization.
CRISPR/Cas9-derived knockout of Gdf6 attenuated migration of murine IMCD3 cells, an effect rescued by expression of
wild-type but not mutant GDF6, indicating affected variant function regarding a fundamental developmental process.
Knockdown of gdf6 in Xenopus laevis resulted in impaired pronephros development. Altogether, we identified rare
heterozygous GDF6 variants in 1.6% of all renal anomaly patients and 5.4% of renal anomaly patients additionally
manifesting skeletal, ocular, or auricular abnormalities, adding renal hypodysplasia and fusion to the phenotype spectrum of
GDF6 variant carriers and suggesting an involvement of GDF6 in nephrogenesis.
Introduction
Structural defects of the kidney range from renal agenesis,
hypoplasia, and dysplasia to duplication and fusion phe-
notypes, such as horseshoe kidneys and crossed fused renal
ectopia. The latter is a rare form of renal anomaly where
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two fused kidneys come to lie on the same side of the spine,
each with their own ureter, one of which crossing the
midline to enter the bladder on the contralateral side. As
other renal anomalies are also frequently associated with
malformations of the urinary tract, such as ureteropelvic or
ureterovesical junction obstruction with hydroureter, or
vesicoureteral reflux (VUR), the term congenital anomalies
of the kidney and urinary tract (CAKUT) has been coined to
subsume these abnormalities. Taken together, CAKUT
phenotypes account for 15–30% of all prenatally detected
congenital malformations [1], and cause around 40% of
cases with end-stage kidney disease in children and ado-
lescents [2], thus representing a significant health burden. In
around 85% of patients, CAKUT occur sporadically, while
in the remaining 15% of cases familial occurrence is
observed. CAKUT may occur in isolation or be part of a
mild or complex syndromal disease. Since over 500 syn-
dromes have been associated with CAKUT [3], it is not
surprising that one-third of patients are additionally affected
by extrarenal manifestations [4], and that around 20% of
patients may have a genetic disorder that is not detected
based on standard clinical evaluation [5]. Although over 50
genes are known to cause CAKUT in humans if mutated
[6, 7], <20% of CAKUT manifestations can be explained by
aberrations in these genes [8, 9], indicating a high genetic
heterogeneity underlying these defects and making clear the
need to identify new genes associated with renal develop-
ment and malformation. However, the identification of
causative genetic variants in cohorts of sporadic CAKUT
patients and CAKUT families is hampered by variable
expressivity, meaning that individuals harboring the same
variant may have very different phenotypes within the
broad CAKUT spectrum, and by incomplete penetrance
implying that variant carriers may exist that are not affected
by a CAKUT phenotype at all.
In the last few years, whole-exome sequencing (WES)
using next generation sequencing (NGS) techniques was
successfully applied to the study of germline variation
underlying human CAKUT [10]. Thereby, novel CAKUT-
associated genes were identified e.g., by using a linkage-
based strategy in large CAKUT families [11, 12], a double
hit-based strategy in smaller CAKUT families [13], an
overlapping strategy in a cohort of patients with similar
phenotypes [14], and a trio-based de novo strategy in
patients with sporadic CAKUT [15, 16]. In addition, WES
has improved the diagnostic yield of genetic CAKUT cau-
ses, particularly in syndromic cases [9].
Here, in an effort to identify new genes associated with
renal malformation in humans, we used a WES approach to
determine the genetic variation underlying renal anomalies
in an index patient with syndromic CAKUT. By a
targeted mutational screen in a cohort of 193 further
patients with renal anomalies, expression analyses, and
functional studies in a cellular system modified by
CRISPR/Cas9 genome engineering and an animal model,
we suggest that the candidate gene identified in the index




This study was conducted in accordance with the Declara-
tion of Helsinki and approved by the Ethics Boards of
Hannover Medical School, Hannover, Germany, Oslo
University Hospital, Oslo, Norway, and University Chil-
dren’s Hospital, Skopje, North Macedonia. Each family
provided informed consent for participation in the study. A
total of 194 patients with renal anomalies comprising 122
males and 72 females with a mean age of 10 years (range
1–35 years) were analyzed. Renal phenotypes of all 194
patients are listed in Supplementary Table 1. Rare hetero-
zygous GDF6 variants predicted to be disease causing were
detected in families F006, H435, and N038.
Family F006
The index patient, F006.II.1, born as the second daughter of
non-consanguineous German parents is now 3 years old.
After birth, renal ultrasound was notable for left-sided
crossed fused renal ectopia (Fig. 1a). Voiding cystoure-
thrography revealed two megaureters, both with orthotopic
ostia in the bladder, one connected to the superior pelvis,
and the other to the inferior pelvis of the left-sided fused
kidneys (Fig. 1b), and grade-IV VUR in both ureters.
Recurrent urinary tract infections were diagnosed. The
patient also showed a left-convex torsion scoliosis, mal-
formations of multiple vertebral bodies of the cervical and
thoracic spine including butterfly and fused vertebrae, and a
missing fifth sacral vertebral body and coccyx (Fig. 1c, d).
A tethered cord was diagnosed because of a low standing
conus medullaris, and detethering surgery was performed.
The patient also presented with anal atresia and a recto-
vestibular fistula, which was surgically corrected. By
echocardiography, two small muscular ventricular septal
defects and a patent foramen ovale were diagnosed. Oph-
thalmologic examination revealed anisometropia with
hyperopia, astigmatism, amblyopia, suspected micro-
phthalmia, corneal opacities, and a best-corrected visual
acuity of 0.16 in the left eye and of 1.0 in the right eye. In
addition, the patient presented with a left-sided auricle
dysplasia and aplasia of the external auditory canal, while
the cochleae and the semicircular canals were unremarkable
on both sides according to cranial MRI. Neurological
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examination was normal and no developmental or intel-
lectual deficits were observed. Her 6-year-old sister and 36-
year-old mother presented with right-sided preauricular pits,
while renal ultrasound examinations revealed no abnorm-
alities. Her father was clinically unremarkable and renal
sonography was normal.
Family H435
Twelve-year-old patient H435.II.1 was born as the second
son of non-consanguineous Macedonian parents. After
birth, the boy presented with a right-sided normal kidney
and a left-sided hypodysplastic kidney, a diagnosis
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confirmed by ultrasound at age 11 years (Fig. 1e, f). The left
kidney could not be visualized by a radionuclide scan using
DMSA indicating that it is not functional. In addition, the
patient showed a mild torsion scoliosis. The philtrum
appeared shorter than usual, a high-arched palate and mal-
occlusion due to prognathism were noted. His ears were of
normal size but had a slight lop deformity. Except for the
presence of a short frenulum, external genitalia were unre-
markable. No developmental or intellectual deficits
were noted. His 15-year-old brother also had high-arched
palate and lop ears, whereby particularly the right ear was
smaller and showed a poorly developed antihelix. A
triangular-shaped chin was observed. Neurological exam-
ination was normal and no developmental or intellectual
deficits were diagnosed. His 1-year-old sister was clinically
unremarkable, but renal ultrasound or other examinations
were not performed. His father presented with short stature.
Renal sonography of both parents was normal.
Family N038
Fourteen-year-old patient N038.II.1 is the only daughter of
an African mother and a Caucasian father. She was pre-
natally diagnosed with oligohydramnios and small kidneys.
Renal ultrasound at age 6 months showed bilateral renal
hypodysplasia as indicated by reduced size, hyper-
echogenicity, and reduced corticomedullary differentiation
of the kidneys (right kidney shown in Fig. 1g). After birth,
she additionally presented with macrocephaly, high-arched
palate, and short narrow palpebral fissures. She required
kidney transplantation at the age of 5 years and was re-
transplanted at 9 years of age due to chronic rejection and
noncompliance with drug treatment. At 14 years, she has
poor kidney function and several comorbidities such as
obesity and hypertension.
Animals
Husbandry and treatment of Xenopus laevis were approved
by the Regierungspräsidium Freiburg, Germany. Mice were
kept in accordance with the National Institutes of Health
guidelines for the care and use of laboratory animals. All
experiments on mice were approved by the Ethics Board of
the Lower Saxony State Office for Consumer Protection and
Food Safety. Murine embryos for gene expression analysis
were derived from matings of wild-type mice with NMRI
background. For timed pregnancies, vaginal plugs were
checked in the morning after mating, and noon was defined
as embryonic day (E) 0.5. Embryos were dissected in
phosphate-buffered saline (PBS; Merck, Darmstadt,
Germany) and fixed in 4% paraformaldehyde in PBS fol-
lowed by dehydration using increasing methanol con-
centrations, i.e., incubation in 25%, 50%, and 75%
methanol for 1 h each. Fixed embryos were stored in 100%
methanol at −20 °C prior to in situ hybridization analyses.
WES and targeted GDF6 sequencing
WES was performed on whole-blood DNA of one
patient–sibling–parents index family, 30 additional patients
with renal malformations, and 74 control individuals using
the SureSelectXT Human All Exon V4 target enrichment kit
(Agilent, Santa Clara, CA, USA) on a HiSeq 2000 (Illu-
mina, San Diego, CA, USA) sequencer or the SureSelectXT
Human All Exon V5+UTRs target enrichment kit (Agilent)
on a HiSeq 2500 (Illumina) sequencer. All samples were
sequenced to a mean target coverage of >50×. Sequencing
data were aligned to the human reference genome (hg19)
using the Biomedical Genomics Workbench (Qiagen, Hil-
den, Germany). WES data of the index family were anno-
tated and prioritized using Ingenuity Variant Analysis
(Qiagen) and our in-house NGS data analysis workflow as
described in “Results” and summarized in Supplementary
Tables 2 and 3. Using conventional chain termination pro-
tocols and a 3130XL Genetic Analyzer (Thermo Fisher
Scientific, Waltham, MA, USA), all coding exons and
adjacent intronic regions of GDF6 were analyzed for
sequence variants in 163 further patients with kidney
anomalies, selected GDF6 variants identified by WES were
verified, and familial segregation analysis was done (oli-
gonucleotide sequences are given in Supplementary
Fig. 1 WES and targeted sequencing identified heterozygous rare
GDF6 variants in three of 194 patients with renal anomalies
(1.6%), and in three of 56 patients with renal plus skeletal, ocular
or auricular anomalies (5.4%). a Renal ultrasound of index patient
F006.II.1 was notable for left-sided crossed fused kidney (K) ectopia
with megaureters (U). b Voiding cystourethrography of patient F006.
II.1 revealed grade-IV vesicoureteral reflux into two megaureters (U)
with orthotopic ostia in the bladder (B) and connected to the superior
or inferior dilated kidney (K) pelvis of the fused kidneys. c, d MRI of
the spine of patient F006.II.1 showing malformations of cervical and
thoracic vertebral bodies, e.g., fused and butterfly vertebrae (arrows)
(c) and missing fifth sacral vertebral body and coccyx (arrow) (d). e, f
Renal ultrasound of patient H435.II.1 at the age of 11 years was
unremarkable on the right side (e), while the left kidney was hypo-
dysplastic (f) and nonfunctional on DMSA scan. g Renal ultrasound of
patient N038.II.1 at age 6 months showing renal hypodysplasia, as
indicated by reduced size, hyperechogenicity, and reduced cortico-
medullary differentiation of the right kidney depicted. The left kidney
was also hypodysplastic (not shown), and the patient required kidney
transplantation at 5 years of age. h–j Pedigrees of families F006 (h),
H435 (i), and N038 (j) with colored shading indicating phenotypical
overlap with respect to renal, skeletal, auricular, and ocular anomalies
in individuals with rare GDF6 variants. The GDF6 mutational status
(V1: c.746C>A p.(Ala249Glu), V2: c.112G>C p.(Gly38Arg), WT:
wild-type) is indicated, and corresponding electropherograms are
shown for all analyzed family members (no DNA sample was avail-
able from individual N038.I.2). Clinical and radiological information
was not available from individuals H435.II.3 (1 year of age) or N038.
I.2. L, liver; the kidneys are marked by dotted lines (e–g).
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Table 4). Nucleotide numbering of the identified variants
reflects the nucleotide position in the coding sequence of
human GDF6 mRNA (https://www.ncbi.nlm.nih.gov/
nuccore/NM_001001557.4) (Supplementary Fig. 1).
Immunohistochemistry, RNA in situ hybridization,
CRISPR/Cas9 genome engineering and cellular
assays, knockdown and rescue experiments in
Xenopus laevis
Procedures are described in “Supplementary materials”
(including Supplementary Tables 5–8).
Statistical analysis
Statistical analysis was done using MATLAB and Statistics
Toolbox Release 2018b (The MathWorks, Inc., Natick,
MA, USA). Student’s t-test or Fisher’s exact test were used,
as applicable, and p values are indicated (*p < 0.05, **p <
0.01, and ***p < 0.001).
Results
Using WES, a rare heterozygous GDF6 missense
variant, c.746C>A p.(Ala249Glu), was detected in
the index patient
Under the assumption that NGS techniques are particularly
successful in identifying the genetic cause in patients with
syndromic CAKUT, we applied WES to whole-blood DNA
of female patient F006.II.1 with a renal malformation (i.e.,
crossed fused renal ectopia) as well as skeletal (e.g., sco-
liosis, fused and butterfly vertebrae) (Fig. 1a–d), auricular
(i.e., auricle dysplasia and aplasia of the external auditory
canal), ocular (e.g., anisometropia), and other extrarenal
anomalies, and of her mother, father, and sister who were
not affected by renal anomalies. As no rare de novo,
homozygous, or compound-heterozygous variants predicted
to be disease causing could be detected in the high-quality
exome data of patient F006.II.1, variants were prioritized
using the strategy summarized in Supplementary Table 2.
Prioritization of high-quality variants of patient F006.II.1 by
seriousness, rareness, exclusiveness, and localization in
genes (n= 207) reported to be mutated in at least one
patient with syndromic CAKUT according to our in-house
gene list yielded five rare (minor allele frequency
(MAF) ≤ 1%) non-silent variants not present in controls and
predicted to be disease causing by at least one prediction
tool (MutationTaster, SIFT, or PolyPhen-2) (Supplementary
Tables 2 and 3). One of these five variants, the GDF6
variant c.746C>A p.(Ala249Glu), was presumed causative
in patient F006.II.1 because it is reported to be disease
causing by the HGMD Professional (v2018.2; Qiagen) and
ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/) databases
in patients with skeletal and ocular anomalies [17–22]
matching the patient’s extrarenal phenotype (Supplemen-
tary Table 9). By direct sequencing, the GDF6 c.746C>A
variant was confirmed to be heterozygous in the patient as
well as in her sister and mother, both affected by the same
mild auricular anomaly (Fig. 1h). The c.746C>A variant is
located in the second exon of GDF6 and occurs with a MAF
of 0.001948 in the global population cohort and a MAF of
0.003783 in the non-Finnish European cohort of the Gen-
ome Aggregation Database (gnomAD v2.1.1) (Table 1).
The amino acid alanine at position 249 is evolutionary
conserved and located in the propeptide/prodomain of
GDF6 (Supplementary Fig. 1). Based on the ACMG/AMP
2015 guidelines [23], we classified the c.746C>A variant as
“pathogenic” (Table 1).
Heterozygous GDF6 missense variants were
detected in a total of three of 194 patients (1.6%)
with renal malformations and three of 56 patients
(5.4%) with renal plus skeletal, ocular or auricular
anomalies
Having identified a GDF6 variant previously associated
with skeletal and ocular anomalies in a patient presenting
with these phenotypes and additionally with a renal mal-
formation, we explored the frequency of rare GDF6 variants
in a cohort of patients with renal anomalies. A total of 193
additional cases were either analyzed by WES (30 patients)
or targeted sequencing of the GDF6 gene (163 patients). By
targeted sequencing, we identified the GDF6 variant
c.746C>A in an additional patient, H435.II.1 from North
Macedonia, presenting with a hypodysplastic left kidney
(Fig. 1f, i) that was nonfunctional on DMSA scan, mild
skeletal, and auricular phenotypes, i.e., torsion scoliosis,
high-arched palate, and lop ears (Table 1). The GDF6
c.746C>A variant was detected in a heterozygous state in
the patient, his father who presented with short stature, his
brother who had a high-arched palate and lop ears, and a 1-
year-old sister who was not further examined (Fig. 1i).
Another rare heterozygous GDF6 missense variant,
c.112G>C p.(Gly38Arg), was detected by targeted
sequencing in female patient N038.II.1 presenting with
bilateral renal hypodysplasia (Fig. 1g) requiring kidney
transplantation at age 5 years in addition to skeletal, i.e.,
macrocephaly and high-arched palate, and ocular, i.e., short
narrow palpebral fissures, phenotypes (Fig. 1j and Table 1).
As the c.112G>C variant was not inherited from her Cau-
casian father, it may be a de novo variant or have been
inherited from her African mother (Fig. 1j) from whom no
DNA sample was available for clarification. Located in the
first exon of GDF6 (Supplementary Fig. 1), the c.112G>C
Rare heterozygous GDF6 variants in patients with renal anomalies










































at age 5 years
Features of Klippel–Feil syndrome 1 (i.e.,



























Features of Klippel–Feil syndrome 1 (i.e.,
vertebral segmentation defects including
fusions, scoliosis, left-sided auricle
dysplasia, and aplasia of the external
auditory canal), anal atresia,
rectovestibular fistula, small ventricular




























Features of Klippel–Feil syndrome 1 (i.e.,
scoliosis, high-arched palate), lop ears,











NCBI reference sequence: NM_001001557.4. Ensembl transcript ID: ENST00000287020.
Variants were submitted to ClinVar (accession numbers SCV001334266-SCV001334268; http://www.ncbi.nlm.nih.gov/clinvar/).
SNP single-nucleotide polymorphism, MAF minor allele frequency in global/non-Finnish European/African population according to gnomAD v2.1.1.
aAccording to GRCh37/hg19.








variant occurs with a MAF of 0.000656 in the global
population cohort, a MAF of 0.007016 in the African
population cohort, and is not present in the non-Finnish
European cohort of the gnomAD database v2.1.1 (Table 1).
While the c.112G>C variant was of “uncertain significance”
based on the ACMG/AMP 2015 guidelines [23], the pre-
diction tools SIFT and PolyPhen-2 rated it as “damaging” or
“possibly damaging” (Table 1). The amino acid glycine at
position 38 is evolutionary highly conserved. In total, we
detected rare heterozygous GDF6 missense variants pre-
dicted to be disease causing in 3 of 194 families with renal
anomalies (1.6%). Clinical or radiological reevaluation of
the skeleton, eye or ear revealed skeletal, ocular, or auri-
cular abnormalities in 56 of the 194 patients with renal
anomalies analyzed. As the three GDF6 variant carriers
were among these patients, 3 of 56 patients (5.4%) with
renal plus skeletal, ocular, or auricular features carried
GDF6 variants with a disease-causing prediction, a sig-
nificant frequency increase compared with that in renal
anomaly patients without abnormalities of the skeleton, eye,
or ear (0/138, p= 0.0231, Fisher’s exact test).
GDF6 is expressed in the infant human kidney, and
in the developing murine urogenital system and
pronephros of Xenopus laevis
Having detected rare GDF6 variants in patients with renal
anomalies, we went on to explore a possible role for GDF6 in
kidney development by determining the expression pattern of
GDF6 in the infant human kidney as well as inMus musculus
and Xenopus laevis during development. GDF6 protein
expression was detected in the human infant kidney, most
prominently in proximal tubules, by immunohistochemistry
(Fig. 2a). During lower vertebrate development, expression of
gdf6 was observed in the area of the pronephros, the
embryonic kidney of Xenopus laevis, with particular
enhancement in the tissue just adjacent to the pronephric
tubule at stage 38 by whole-mount RNA in situ hybridization.
Expression at this stage was also detected around the eye
vesicle, branchial arches, notochord, and neural tube of
Xenopus laevis embryos (Fig. 2b). During murine urogenital
system development, Gdf6 mRNA was present in the ureteric
tips at E11.5 shortly after onset of metanephros development.
At E13.5, expression of Gdf6 in the kidney reached its peak
and was found in all compartments, i.e., the ureter and ureteric
tips, of the developing ureteric tree. After onset of collecting
duct differentiation at E14.5, Gdf6 transcript levels decreased
in the kidney, and renal expression was barely detectable at
E18.5. At E11.5, Gdf6 was also detectable in the mesothelial
lining of the abdominal cavity and weakly in the epithelium of
the urogenital sinus, which develops into the bladder.
Expression in the bladder urothelium vanished after E14.5.
Gdf6 mRNA was also found in the nephric duct or
differentiated vas deferens of male embryos at all analyzed
stages (Fig. 2c, data partly not shown).
Knockout of Gdf6 in murine inner medullary
collecting duct (mIMCD3) cells impairs cell
migration, an effect rescued by expression of wild-
type not mutant GDF6 in Gdf6−/− mIMCD3 cells
Next, we generated an in vitro test system to determine
whether GDF6 impacts cell migration, a central process in
development, and to assess whether the identified GDF6
variants affect this function. Using CRISPR/Cas9 technol-
ogy, a single guide RNA targeting the first coding exon of
Gdf6 was applied to knockout Gdf6 in mIMCD3 cells.
Two Gdf6−/− mIMCD3 cell clones with frameshift
variants predicted to result in premature stop codons and
nonfunctional proteins were identified, i.e., clone 32
harboring the homozygous Gdf6 variant c.377_378delCA
p.(Ser126Cysfs*2), and clone 34 containing the biallelic
Gdf6 variants c.373_376delAAGT p.(Lys125Glnfs*9) and
c.377_378delCA p.(Ser126Cysfs*2) (Supplementary
Fig. 2). A mIMCD3 cell clone with no mutational event in
Gdf6 (clone 2, Gdf6+/+) was also identified and used as a
control (Supplementary Fig. 2). No differences in cell via-
bility were observed when comparing mIMCD3 cells and
Gdf6+/+ mIMCD3 cell clone 2 with the Gdf6−/− mIMCD3
cell clones 32 or 34 using a cell viability assay (Supple-
mentary Fig. 3).
A time series analyzing mIMCD3 cell migration in a
wound healing assay resulted in a reduction of the cell-free
area by 50% after 8 h (Supplementary Fig. 4). Therefore, in
subsequent analyses the cell-free areas were determined and
compared at 0 h and 8 h. While migration of mIMCD3 cells
and Gdf6+/+ mIMCD3 cell clone 2 did not differ sig-
nificantly, migration of Gdf6−/− mIMCD3 cell clones 32
and 34 was significantly decreased compared with Gdf6+/+
mIMCD3 cell clone 2 (p= 0.002 and p= 0.005, respec-
tively; Fig. 3a), thereby providing evidence that Gdf6
knockout impacts cell migration. Migration was also sig-
nificantly impaired in Gdf6+/− mIMCD3 cell clone 30
versus Gdf6+/+ mIMCD3 cell clone 2 (p= 0.041; Supple-
mentary Fig. 5), indicating an effect on migration of het-
erozygously mutated cells, a cellular model for patients with
heterozygous GDF6 variants. A significant increase in
migration of Gdf6−/− mIMCD3 cell clone 32 stably trans-
fected with a wild-type GDF6 expression construct was
detected compared with Gdf6−/− mIMCD3 cell clone 32
transfected with empty vector (p= 0.007; Fig. 3b and
Supplementary Fig. 6), showing that re-expression of
human wild-type GDF6 can rescue the reduced migration.
In contrast, migration of Gdf6−/− mIMCD3 cell clone 32
transfected with constructs expressing GDF6 variants
c.112G>C or c.746C>A versus GDF6 wild-type was
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Fig. 2 GDF6 is expressed in the infant kidney, during pronephros
development in Xenopus laevis and murine urinary tract devel-
opment. a By immunohistochemical detection of GDF6 and the
marker proteins aquaporin-1 (AQP1, straight and convoluted proximal
tubule and thin descending limb of loop of Henle), aquaporin-2
(AQP2, collecting duct), and Tamm-Horsfall protein (THP, thick
ascending limb of loop of Henle and distal tubule) in a normal human
infant kidney section, GDF6 localized most prominently to proximal
tubules. b By whole-mount RNA in situ hybridization in Xenopus
laevis at stage 38, gdf6 was expressed in the tissue surrounding the
pronephric tubule (arrow, enlarged image) as well as in the developing
eye, branchial arches, notochord, and neural tube. c RNA in situ
hybridization analysis on sagittal sections of the murine kidney and
bladder from E11.5 to E18.5. Gdf6 expression was present in all
compartments of the developing ureteric tree, including the ureteric
tips (ut) and the ureter (u), at E11.5 to E14.5, dropped after onset of
collecting duct differentiation, and was barely detectable at E18.5
(p pelvis, c cortex). In the lower urogenital tract, Gdf6 expression was
found in the mesothelial lining (m) of the abdominal cavity at E11.5, in
the undifferentiated urothelium of the urogenital sinus (us) and the
bladder (bl) until E14.5, and in the nephric duct (nd) of male embryos
at all analyzed stages (data partly not shown). Sections from three
independent murine specimens were analyzed.
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significantly reduced (p= 0.003 and p= 0.008, respec-
tively; Fig. 3b and Supplementary Fig. 6), demonstrating
that the identified GDF6 variants are not functional in this
assay.
Morpholino (MO) knockdown of gdf6 in Xenopus
laevis impairs pronephros development
To explore a possible role of gdf6 in renal development
in vivo, we performed gdf6 knockdown unilaterally using a
specific gdf6 antisense MO in Xenopus laevis tadpoles, and
analyzed the developing pronephros, constituting the
embryonic kidney in lower vertebrates, at stage 39 (Fig. 4).
The pronephric area, calculated as log2 ratio of the injected
and uninjected side of the tadpole, was significantly reduced
after gdf6 MO injection compared with control MO injec-
tion (p= 7.6 × 10−13; Fig. 4). This effect was partially
rescued by co-injection of GDF6 mRNA with gdf6 MO that
increased the pronephros area significantly compared with
injecting gdf6 MO alone (p= 0.035; Fig. 4). Thereby, we
demonstrate a role for gdf6 in pronephric tubule develop-
ment in Xenopus laevis.
Discussion
In the present study systematically investigating a role of
GDF6 in renal anomalies, we identified rare heterozygous
GDF6 variants in 1.6% of patients with kidney malforma-
tions. Initially, we found GDF6 to be associated with renal
malformation by an unbiased screen for germline variation
in a patient with renal as well as skeletal, auricular, ocular,
and other anomalies. This patient had been chosen for WES
analysis because NGS technologies have been particularly
successful in identifying causative genes in syndromic
CAKUT [9]. Subsequently, we detected two further renal
anomaly patients with rare heterozygous GDF6 variants
among the 193 patients additionally analyzed. In line with
the extrarenal manifestations of our three renal anomaly
patients carrying GDF6 variants, variants in GDF6 have
previously been reported in patients with skeletal pheno-
types, i.e., (i) Klippel–Feil syndrome (KFS) with vertebral
segmentation defects frequently associated with scoliosis,
rib abnormalities, and Sprengel’s deformity now known as
KFS1 [17, 18], (ii) Chiari malformations [17, 24], and (iii)
multiple synostoses syndrome including carpal and tarsal
Fig. 3 Knockout of Gdf6 impacts migration of murine IMCD3
cells, an effect partially reversed by expression of wild-type not
mutant GDF6. a Relative to mIMCD3 cells, migration of Gdf6−/−
mIMCD3 cells (clones 32 and 34) was significantly decreased com-
pared with Gdf6+/+ mIMCD3 cell clone 2. b The effect of Gdf6
knockout in mIMCD3 cell clone 32 expressing empty vector (vector
control) relative to mIMCD3 cells was partially rescued by stable
expression of human wild-type (WT) GDF6 in mIMCD3 cell clone 32.
Conversely, relative cell migration of Gdf6−/− mIMCD3 cell clone
32 stably expressing GDF6 c.112G>C or c.746C>A variants was
significantly reduced compared with Gdf6−/− mIMCD3 cell clone
32 stably expressing wild-type GDF6. All results are mean ± SD from
three independent experiments. Scale bar: 150 µm. N.s. not significant;
**p < 0.01; ***p < 0.001.
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fusions [25–27], as well as ocular phenotypes, i.e., (i)
microphthalmia [20–22], (ii) coloboma [18, 28], (iii) Leber
congenital amaurosis or juvenile retinitis pigmentosa [19],
and (iv) glaucoma [29]. By adding three patients with renal
anomalies to the two patients previously reported [17, 18], a
total of 5 of 86 (5.8%) individuals carrying rare GDF6
variants described here and in the literature (Supplementary
Table 9) are known to be affected by congenital kidney
malformations. This finding suggests that renal sonography
is warranted in patients carrying rare GDF6 variants irre-
spective of the other abnormalities or disorders they may
present with. Vice versa, GDF6 mutational analysis may be
advisable in patients with renal anomalies, in particular in
those cases additionally affected by the skeletal and ocular
phenotypes previously associated with rare GDF6 variants
and also present in the renal anomaly patients with GDF6
variants of this study. Accordingly, the percentage of rare
GDF6 variants in patients with renal plus bone, eye, or ear
abnormalities was 5.4%, significantly higher than in renal
anomaly patients without these extrarenal manifestations. In
this context, it is notable that we detected one GDF6 var-
iant, the missense variant c.746C>A, recurrently in renal
anomaly patients, resulting in a significant frequency
increase compared with the cohort of the 1000 Genomes
Project. Previously, the GDF6 c.746C>A variant was
reported in patients with KFS-like skeletal anomalies
[17, 18, 20], Chiari malformation [24], micro- or anoph-
thalmia [20–22], and Leber congenital amaurosis or juve-
nile retinitis pigmentosa [19] (Supplementary Table 9),
demonstrating that it can be associated with a spectrum of
different phenotypes. In line with these findings, we
detected skeletal anomalies in four of seven GDF6
c.746C>A variant carriers from two families, and ocular
anomalies in one carrier. Similar to kidney malformations
that were present in two of the seven GDF6 c.746C>A
variant carriers here, penetrance is reduced for these
abnormalities. Reduced penetrance is a known feature
associated with renal anomalies. This is exemplified by a
family with Stickler syndrome and a heterozygous nonsense
variant in the BMP4 gene encoding bone morphogenetic
protein 4, a ligand related to GDF6, with renal dysplasia
in only one of five family members carrying the BMP4
variant [30].
GDF6 encodes growth differentiation factor 6, a member
of the BMP family within the transforming growth factor
beta (TGF-β) superfamily of ligands that utilize type I and
type II transmembrane serine–threonine kinase receptors
[31]. Therefore, in GDF6 variant carriers reduced pene-
trance for renal malformations may be explained by the
complexity of TGF-β signaling comprising numerous
ligands (around 30), receptors, and downstream interacting
proteins [31], suggesting some redundancy. The GDF6
amino acid sequence consists of three domains. These are a
signal peptide, a propeptide/prodomain, and a mature
receptor-binding carboxy-terminal TGF-domain that is
highly conserved between species, i.e., it is more than 90%
identical in Xenopus laevis and mouse [32]. Interestingly,
74% of the GDF6 variants detected in patients with dif-
ferent phenotypes (Supplementary Table 9), including the
recurrent c.746C>A variant and the c.112G>C variant
identified in renal anomaly patients here, affect amino acids
located in the prodomain of the GDF6 sequence. Although
it is less conserved, the prodomain of TGF-β superfamily
ligands is known to regulate the synthesis, extracellular
localization, and activity of these proteins [33]. The pro-
domain of BMP4, another member of the BMP family of
ligands, for instance, is necessary to generate stable BMP4/
7 heterodimers with enhanced bioactivity in vivo [34].
Fig. 4 Morpholino (MO) knockdown of gdf6 in Xenopus laevis
impairs pronephros development. Xenopus laevis stage (st.) 39
tadpoles were unilaterally injected with a control MO or a translation-
blocking gdf6 MO with or without co-injection of GDF6 mRNA, and
stained with fluorescein-labeled lectin to visualize the pronephros. The
ratios of the pronephros areas of the injected (inj.) and the uninjected
(uninj.) side of the embryo were calculated and log2 transformed.
Knockdown with the gdf6 MO led to a significantly reduced prone-
phros area. This effect was significantly rescued by the co-injection
of GDF6 mRNA. Results are mean ± SEM from n embryos analyzed
in four independent experiments. N.s. not significant; *p < 0.05;
***p < 0.001.
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Therefore, it is not unexpected that although the c.746C>A
variant affects an amino acid located in the prodomain of
GDF6, the activity of variant GDF6 was significantly
decreased in a SOX9-reporter luciferase assay [18], and
amounts of variant pre-pro-protein and mature ligand were
reduced in the media of transfected cells [19] compared
with wild-type. Furthermore, we show here that impaired
cell migration of murine Gdf6 knockout cells from the renal
inner medullary collecting duct is rescued by expression of
wild-type GDF6 but not of c.746C>A and c.112G>C var-
iants, indicating that both are hypomorphic variants with
respect to cell movements, a fundamental process in
development.
BMP signaling is highly implicated in embryogenesis
including nephrogenesis and development [35–38].
CAKUT phenotypes were observed with high penetrance
in mice carrying a heterozygous or homozygous knockout
for genes encoding BMP ligands such as BMP4 [39],
BMP7 [40], and GDF11 [41]. Pleiotropic defects have
been described as a result of Gdf6 knockout, knockdown,
or variation in mice, zebrafish, or Xenopus laevis includ-
ing defects in joint, ligament, and cartilage formation
causing carpal and tarsal fusions and coronal craniosy-
nostosis [42], altered tail tendon fascicles [43], shorter
lengths of digits and dermal flat bones in the skull [44],
microphthalmia, anophthalmia, and coloboma [20, 45].
Whether urogenital tract anomalies exist has not pre-
viously been examined in these animal models. Based on
the results from our expression and functional studies and
the finding that other BMP ligands, such as BMP4, reg-
ulate the budding site and elongation of the developing
mouse ureter [39], we propose that the rare GDF6 variants
detected in five renal anomaly patients here and pre-
viously [17, 18] may be causally related to their kidney
malformation. This proposal is in line with the spectrum
of renal abnormalities seen in GDF6 variant carriers that
includes renal agenesis [17] and renal hypodysplasia (two
cases here), two anomalies also found in patients carrying
BMP4 variants [46]. Kidney agenesis or hypoplasia are
potentially caused by defects in ureteric budding and
branching of the ureteric tree induced by abberant BMP
signaling as detected in Bmp4 heterozygous knockout
mice [39]. It is quite conceivable that such budding and
branching defects giving rise to missing or small dys-
plastic kidneys also occur in human carriers of rare GDF6
variants because the developing ureteric tree expresses
Gdf6, and migration of collecting duct cells that originate
from the ureteric tree is impaired by Gdf6 knockout, as
shown here. Similarly, pronephros size was reduced by
gdf6 knockdown in Xenopus laevis. We and others addi-
tionally observed kidney abnormalities involving renal
fusions, i.e., a horseshoe kidney [18] and a crossed fused
renal ectopia (one case here), in patients with rare GDF6
variants, similar to the skeletal fusions seen (Supple-
mentary Table 9). These data imply that BMP signaling is
also linked to skeletal and renal fusions, similar to
observations in a conditional Bmp4 knockout mouse in
which reduced BMP signaling resulted in hindlimb fusion
[47]. According to an established view, renal fusions
result as a consequence of abnormal renal ascent during
embryogenesis [48], possibly connecting GDF6 to the
migration of the kidneys as also suggested by our cell
migration studies.
In summary, we identified rare heterozygous GDF6
variants in 1.6% of all patients of our renal anomaly cohort,
and in 5.4% of those patients additionally manifesting
skeletal, ocular, or auricular abnormalities suggesting that
GDF6 is associated with human kidney malformations. The
phenotype spectrum identified in renal anomaly patients
with GDF6 variants ranged from hypodysplasia to fusion.
Furthermore, Gdf6 expression in the murine developing
ureteric tree, diminished migration of murine Gdf6−/− col-
lecting duct cells and impaired pronephros development
after gdf6 knockdown in Xenopus laevis may support a role
of GDF6 in kidney development.
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